Biocon’s Bengaluru Unit Receives EIR From U.S.FDA
An employee in protective clothing works inside the research and development center at the Biocon Ltd. campus in Bengaluru. (Photographer: Dhiraj Singh/Bloomberg)

Biocon’s Bengaluru Unit Receives EIR From U.S.FDA

Bookmark
Biotechnology firm Biocon Ltd. today said it has received Establishment Inspection Report (EIR) from the U.S. health regulator on closure of inspection of its sterile drug product manufacturing fac...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.